TOP SELLING BIOLOGICS MARKET - GAINING TRACTION IN THE PHARMACEUTICAL INDUSTRY AND THE GROWING FUTURE POTENTIAL

 

Roots Analysis has announced the addition of Top Selling Biologics Market, 2021-2030 report to its list of offerings.

 

As of today, most of the top revenue generating drugs, across the globe, are biologics. During our research, we were able to identify 67 top selling biologics (revenues equal to or above USD 500 million in 2020).

 

To request a sample copy / brochure of this report, please visit this:  https://www.rootsanalysis.com/reports/top-selling-biologics-market/request-sample.html 

 

Top selling biologics market has so far been primarily led by industry players. Majority of industry players have taken a step towards investing their time and resources for the development of biologic therapies.

  

Genentech, Amgen, Janssen Biotech, Sanofi and Novo Nordisk are amongst the major players in this domain. Biogen, AstraZeneca, Merck, Bristol Myers Squibb, GlaxoSmithKline, Alexion Pharmaceuticals, AbbVie and Novartis are other players that have entered the Top Selling Biologics domain in the past.

 

 

It is worth highlighting that most of the therapies are monoclonal antibodies capture the highest share (54%) of the top selling biologics market. This can be attributed to the various advantages offered by them, including high reproducibility and specificity. It is also worth mentioning that these therapeutic modalities are being used for many cancer indications. Further, most of the top selling biologics are currently delivered via subcutaneous route of administration. However, most of the top selling biologics are available in the form of vials. This can be attributed to the better sterility assurance and reduced particle presence offered by such packaging formats. [1]

 

To request a customization to this report –  https://www.rootsanalysis.com/reports/top-selling-biologics-market/request-customization.html

 

 Key Questions Answered

  • Which biologics have achieved blockbuster status in the last 1-2 years?
  • Who are the leading players engaged in the development of top selling biologics?
  • Which key clinical conditions are presently targeted by top selling biologics?
  • What are the historical global sales of top selling biologics?
  • Which product life cycle management strategies are most commonly adopted by players to extend the life of their top selling products?
  • What is the current annual treatment cost associated with top selling biologics?
  • Which regions have emerged as key hubs for conducting clinical studies focused on top selling biologics?
  • How has the biosimilars landscape in this market evolved over the past few years?
  • Which factors are likely to influence the evolution of this market?
  • How is the current and future market opportunity likely to be distributed across key market segments?

 

 

For additional details, please visit https://www.rootsanalysis.com/reports/top-selling-biologics-market.htmlOr sales@rootsanalysis.com

 

About Roots Analysis

Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com

 

 

Contact Details 

Ben Johnson 

+1 (415) 800 3415 

ben.johnson@rootsanalysis.com 

 

Roots Analysis 

Web: https://www.rootsanalysis.com/ 

LinkedIn: https://in.linkedin.com/company/roots-analysis 

Twitter: https://twitter.com/RootsAnalysis.com 

Medium: https://medium.com/@RootsAnalysis 

Pinterest: https://in.pinterest.com/RootsanalysisPin/_saved/ 

Quora: https://rootsanalysisinsights.quora.com/

Comments

Post a Comment

Popular posts from this blog

Telemedicine Tools and Software Providers Market, Industry Trends and Global Forecasts, 2021-2030.

  Roots Analysis has announced the addition of Telemedicine Tools and Software Providers Market report to its list of offerings.   The ability to remotely monitor patients using various consultation tools and software have revolutionized modern healthcare practices. The concept of monitoring patients over telephone can be traced back to the 1800’s. However, it was not until 1961, during the National Aeronautics and Space Administration (NASA) space mission, when remote physiologic monitoring of astronauts was efficiently required. Further, with the introduction of cloud computing in 1960s, the remote patient monitoring domain evolved at a significant pace, as these solutions were capable of enabling information sharing and analysis to carry out the process in a more robust manner. Since then, the domain has gained more popularity amongst patients and their caregivers owing to ease of use and cost-effectiveness.     To request a sample copy / brochure of t...
Read more

TIL-based Therapies Market by Target Indications, Industry Trends and Global Forecasts, 2021-2030.

  Roots Analysis  has announced the addition of  TIL-based Therapies Market  report to its list of offerings.   Cancer is one of the leading causes of mortality, accounting for 0.6 million deaths in 2019, in the US alone. The International Agency for Research on Cancer (IARC) states that by 2040, the global burden of cancer is expected to grow to 27.5 million new cases and 16.3 million cancer deaths annually. [1] ,  [2]  Although cancer therapeutics continue to be one of the most active areas in terms of drug development, there is still a significant unmet need in this domain. Conventional cancer treatments, such as chemotherapy, surgery and radiation therapy, have demonstrated very limited efficacy in late-stage cancers. Specifically, chemotherapy and radiation therapy are also associated with several side effects. Their non-specific nature has severe detrimental effects on the patients’ quality of life. [3]   To request a sample copy / bro...
Read more